Stoichiometric inhibition of amyloid beta-protein aggregation with peptides containing alternating alpha,alpha-disubstituted amino acids.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of the American Chemical Society

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 16536517
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cosurfactant and cosolvent effects on surfactant self-assembly in supercritical carbon dioxide.

  2005cited by this paper
• Deciphering the molecular basis of memory failure in Alzheimer's disease.

  2004cited by this paper
• Analysis of the secondary structure of beta-amyloid (Abeta42) fibrils by systematic proline replacement.

  2004cited by this paper
• Alzheimer beta-amyloid homodimers facilitate A beta fibrillization and the generation of conformational antibodies.

  2003cited by this paper
• Facile synthesis of alpha,alpha-diisobutylglycine and anchoring its derivatives onto PAL-PEG-PS resin.

  2003cited by this paper
• Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis

  2003cited by this paper
• Efficient acylation of the N-terminus of highly hindered C(alpha)(alpha)-disubstituted amino acids via amino acid symmetrical anhydrides.

  2002cited by this paper
• Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

  2002cited by this paper
• Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues.

  2001cited by this paper
• Structure-function relationships for inhibitors of beta-amyloid toxicity containing the recognition sequence KLVFF.

  2001cited by this paper
• Control of peptide conformation by the Thorpe-Ingold effect (C alpha-tetrasubstitution).

  2001cited by this paper
• In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692-->Gly) Alzheimer's disease.

  2001cited by this paper
• Approaches to discovery and characterization of inhibitors of amyloid beta-peptide polymerization.

  2000cited by this paper
• Modified-peptide inhibitors of amyloid beta-peptide polymerization.

  1999cited by this paper
• Recognition sequence design for peptidyl modulators of beta-amyloid aggregation and toxicity.

  1999cited by this paper
• Observation of metastable Abeta amyloid protofibrils by atomic force microscopy.

  1997cited by this paper
• Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation.

  1996cited by this paper
• Arrest of -Amyloid Fibril Formation by a Pentapeptide Ligand (*)

  1996cited by this paper
• The toxicity in vitro of beta-amyloid protein.

  1995cited by this paper
• Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4.

  1995cited by this paper

• Fibrillation of Human Serum Albumin Differentially Affected by Asp-, Arg-, and Tyr-Capped Gold Nanoparticles.

  2024cites this paper
• α-Methylation Enables the X-ray Crystallographic Observation of Oligomeric Assemblies Formed by a β-Hairpin Peptide Derived from Aβ

  2024cites this paper
• Exploring Peptido-Nanocomposites in the Context of Amyloid Diseases.

  2023cites this paper
• Aβ-oligomers: A potential therapeutic target for Alzheimer's disease.

  2023cites this paper
• Effects of chirality and side chain length in Cα,α-dialkylated residues on β-hairpin peptide folded structure and stability.

  2023cites this paper
• Molecular Mechanisms of Inhibition of Protein Amyloid Fibril Formation: Evidence and Perspectives Based on Kinetic Models

  2022cites this paper
• Identification of β‐aminopyrrolidine containing peptides as β‐amyloid aggregation inhibitors for Alzheimer's disease

  2022cites this paper
• Destabilization of the Alzheimer’s amyloid-β peptide by a proline-rich β-sheet breaker peptide: a molecular dynamics simulation study

  2021cites this paper
• Rationally designed peptide-based inhibitor of Aβ42 fibril formation and toxicity: a potential therapeutic strategy for Alzheimer's disease

  2020cites this paper
• Sequence and structure-based peptides as potent amyloid inhibitors: A review.

  2020cites this paper
• [Peptide Foldamers: Structural Control and Cell-penetrating Ability].

  2019cites this paper
• Cell‐Penetrating Peptide Foldamers: Drug‐Delivery Tools

  2019cites this paper
• Inhibition of aggregation of physically modified rice proteins by isoconcentration of l-Arg and l-Glu.

  2019cites this paper
• Peptides and peptidomimetics as inhibitors of protein-protein interactions involving β-sheet secondary structures.

  2019cites this paper
• Peptides, Peptidomimetics, and Carbohydrate-Peptide Conjugates as Amyloidogenic Aggregation Inhibitors for Alzheimer's Disease.

  2018cites this paper
• Foldamer Tertiary Structure through Sequence-Guided Protein Backbone Alteration.

  2018cites this paper
• Rationally Designed Peptides and Peptidomimetics as Inhibitors of Amyloid-β (Aβ) Aggregation: Potential Therapeutics of Alzheimer's Disease.

  2017cites this paper
• Capsaicin-Coated Silver Nanoparticles Inhibit Amyloid Fibril Formation of Serum Albumin.

  2016cites this paper
• Thermodynamic and Structural Impact of α,α-Dialkylated Residue Incorporation in a β-Hairpin Peptide.

  2016cites this paper
• Tyrosine- and tryptophan-coated gold nanoparticles inhibit amyloid aggregation of insulin

  2015cites this paper
• Binding Interactions of Agents That Alter α-Synuclein Aggregation.

  2015cites this paper
• Engineering of a peptide probe for β-amyloid aggregates.

  2015cites this paper
• Amyloid-like hierarchical helical fibrils and conformational reversibility in functional polyesters based on L-amino acids.

  2015cites this paper
• Rationally Designed Peptidomimetic Modulators of Aβ Toxicity in Alzheimer's Disease

  2015cites this paper
• (R)‐α‐trifluoromethylalanine containing short peptide in the inhibition of amyloid peptide fibrillation

  2015cites this paper
• Peptides containing β-amino acid patterns: challenges and successes in medicinal chemistry.

  2014cites this paper
• A Cyclic KLVFF‐Derived Peptide Aggregation Inhibitor Induces the Formation of Less‐Toxic Off‐Pathway Amyloid‐β Oligomers

  2014cites this paper
• Mo polyoxometalate nanoclusters capable of inhibiting the aggregation of Aβ-peptide associated with Alzheimer's disease.

  2014cites this paper
• Study on the efficiency and interaction mechanism of a decapeptide inhibitor of β-amyloid aggregation.

  2014cites this paper
• Structural evolution and membrane interactions of Alzheimer's amyloid‐beta peptide oligomers: New knowledge from single‐molecule fluorescence studies

  2014cites this paper
• Rational design and identification of a non-peptidic aggregation inhibitor of amyloid-β based on a pharmacophore motif obtained from cyclo[-Lys-Leu-Val-Phe-Phe-].

  2014cites this paper
• Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs

  2013cites this paper
• Influence of the physiochemical properties of superparamagnetic iron oxide nanoparticles on amyloid β protein fibrillation in solution.

  2013cites this paper
• Novel synthesis of various orthogonally protected Cα-methyllysine analogues and biological evaluation of a vapreotide analogue containing (S)-α-methyllysine.

  2013cites this paper
• Probing the efficacy of peptide-based inhibitors against acid- and zinc-promoted oligomerization of amyloid-β peptide via single-oligomer spectroscopy.

  2012cites this paper
• Observation of molecular inhibition and binding structures of amyloid peptides.

  2012cites this paper
• Peptides for Therapy and Diagnosis of Alzheimer’s Disease

  2012cites this paper
• A Foldamer-Dendrimer Conjugate Neutralizes Synaptotoxic β-Amyloid Oligomers

  2012cites this paper
• Surface-modified protein microspheres capture amyloid-β and inhibit its aggregation and toxicity.

  2011cites this paper
• Macrocyclic β-Sheet Peptides That Inhibit the Aggregation of a Tau-Protein-Derived Hexapeptide

  2011cites this paper
• Structural basis for inhibiting β-amyloid oligomerization by a non-coded β-breaker-substituted endomorphin analogue.

  2011cites this paper
• Synthesis and evaluation of ferrocenoyl pentapeptide (Fc-KLVFF) as an inhibitor of Alzheimer's Aβ₁-₄₂ fibril formation in vitro.

  2011cites this paper
• Designed hairpin peptides interfere with amyloidogenesis pathways: fibril formation and cytotoxicity inhibition, interception of the preamyloid state.

  2011cites this paper
• Targeting Oligomers in Neurodegenerative Disorders: Lessons from α-Synuclein, Tau, and Amyloid-β Peptide

  2011cites this paper
• Effects of peptides derived from terminal modifications of the aβ central hydrophobic core on aβ fibrillization.

  2010cites this paper
• Electric field-driven disruption of a native beta-sheet protein conformation and generation of a helix-structure.

  2010cites this paper
• Strategies for the Inhibition of Protein Aggregation in Human Diseases

  2010cites this paper
• Beta amyloid aggregation inhibitors: small molecules as candidate drugs for therapy of Alzheimer's disease.

  2010cites this paper
• Reversibility of beta-amyloid self-assembly: effects of pH and added salts assessed by fluorescence photobleaching recovery.

  2010cites this paper
• Structure-activity relationships in peptide modulators of β-amyloid protein aggregation: variation in α,α-disubstitution results in altered aggregate size and morphology.

  2010cites this paper
• Fibril aggregation inhibitory activity of the β‐sheet breaker peptides: a molecular docking approach

  2009cites this paper
• Amyloid Aggregation-Mitigating Peptides As Potential Alzheimer's Drugs

  2009cites this paper
• Metal-catalyzed derivatization of C(alpha)-tetrasubstituted amino acids and their use in the synthesis of cyclic peptides.

  2009cites this paper
• Stable right- and left-handed peptide helices containing C(alpha)-tetrasubstituted alpha-amino acids.

  2009cites this paper
• Interaction of Alzheimer's A beta peptide with an engineered binding protein--thermodynamics and kinetics of coupled folding-binding.

  2008cites this paper
• Contrasting In Vivo Effects of Two Peptide-Based Amyloid-β Protein Aggregation Inhibitors in a Transgenic Mouse Model of Amyloid Deposition

  2008cites this paper
• Contrasting in vivo effects of two peptide-based amyloid-beta protein aggregation inhibitors in a transgenic mouse model of amyloid deposition.

  2008cites this paper
• Using a sterically restrictive amino acid as a 19F NMR label to monitor and to control peptide aggregation in membranes.

  2008cites this paper
• Monte Carlo simulations of proteins in cages: influence of confinement on the stability of intermediate states.

  2007cites this paper
• Design and synthesis of chiral alpha,alpha-disubstituted amino acids and conformational study of their oligopeptides.

  2007cites this paper
• Insight Into the Kinetic of Amyloid β (1–42) Peptide Self‐Aggregation: Elucidation of Inhibitors’ Mechanism of Action

  2007cites this paper
• A Soluble Amyloid Fibril Segment to Study Aggregate Formation

  2007cites this paper
• Molecules that Target beta‐Amyloid

  2007cites this paper
• [Design and synthesis of non-proteinogenic amino acids and secondary structures of their peptides].

  2006cites this paper
• Inhibition of beta-amyloid fibrillization by directed evolution of a beta-sheet presenting miniature protein.

  2006cites this paper
• Structural Basis for Inhibiting Β-amyloid Oligomerization by a Non-coded Β-breaker-substituted Endomorphin Analogue

  year unknowncites this paper